Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA3804924
Max Phase: Preclinical
Molecular Formula: C15H22F3NO6
Molecular Weight: 369.34
Molecule Type: Small molecule
Associated Items:
ID: ALA3804924
Max Phase: Preclinical
Molecular Formula: C15H22F3NO6
Molecular Weight: 369.34
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: O=C(C=C1CCC(C(F)(F)F)CC1)N[C@H]1C(O)O[C@H](CO)[C@@H](O)[C@@H]1O
Standard InChI: InChI=1S/C15H22F3NO6/c16-15(17,18)8-3-1-7(2-4-8)5-10(21)19-11-13(23)12(22)9(6-20)25-14(11)24/h5,8-9,11-14,20,22-24H,1-4,6H2,(H,19,21)/b7-5-/t8?,9-,11-,12-,13-,14?/m1/s1
Standard InChI Key: QQPRUPZUZCUVJV-FZUIHZDBSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 369.34 | Molecular Weight (Monoisotopic): 369.1399 | AlogP: -0.42 | #Rotatable Bonds: 3 |
Polar Surface Area: 119.25 | Molecular Species: NEUTRAL | HBA: 6 | HBD: 5 |
#RO5 Violations: 0 | HBA (Lipinski): 7 | HBD (Lipinski): 5 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 11.64 | CX Basic pKa: | CX LogP: -0.40 | CX LogD: -0.40 |
Aromatic Rings: 0 | Heavy Atoms: 25 | QED Weighted: 0.43 | Np Likeness Score: 1.06 |
1. Lin H, Zeng J, Xie R, Schulz MJ, Tedesco R, Qu J, Erhard KF, Mack JF, Raha K, Rendina AR, Szewczuk LM, Kratz PM, Jurewicz AJ, Cecconie T, Martens S, McDevitt PJ, Martin JD, Chen SB, Jiang Y, Nickels L, Schwartz BJ, Smallwood A, Zhao B, Campobasso N, Qian Y, Briand J, Rominger CM, Oleykowski C, Hardwicke MA, Luengo JI.. (2016) Discovery of a Novel 2,6-Disubstituted Glucosamine Series of Potent and Selective Hexokinase 2 Inhibitors., 7 (3): [PMID:26985301] [10.1021/acsmedchemlett.5b00214] |
Source(1):